Evidence map›Paper›PMID 31189939›Full record

ArticleScientific reports2019

Vitamins (A&D) and Isoprenoid (Chenodeoxycholic acid) molecules are accompanied by Th1 immunostimulatory response and therapeutic cure in vivo: possible antileishmanial drugs.

Venkateswara Reddy Gogulamudi, Mohan Lal Dubey, Deepak Kaul, Donfack Jean Hubert, Ramesh Kandimalla, Rakesh Sehgal

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Venkateswara Reddy GogulamudiDepartment of Medical Parasitology, Postgraduate Institute of Medical Education and Research, 160012, Chandigarh, India. gvrmicro@gmail.com.
Mohan Lal DubeyDepartment of Medical Parasitology, Postgraduate Institute of Medical Education and Research, 160012, Chandigarh, India.
Deepak KaulDepartment of Experimental Medicine and Biotechnology, Postgraduate Institute of Medical Education and Research, 160012, Chandigarh, India.
Donfack Jean HubertDepartment of Pharmaceutical Sciences, University of Dschang, P.O. Box 96, Dschang, Cameroon.
Ramesh KandimallaDepartment of Biochemistry, Postgraduate Institute of Medical Education and Research, 160012, Chandigarh, India.
Rakesh SehgalDepartment of Medical Parasitology, Postgraduate Institute of Medical Education and Research, 160012, Chandigarh, India. sehgalpgi@gmail.com.
Post Graduate Institute of Medical Education and Research · INUniversité de Dschang · CM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Investigation of immune modulatory anti-leishmanial molecules is now being strongly encouraged to overcome the immunosuppression manifested during visceral leishmaniasis (VL), resistance, toxicity and high cost associated with conventional therapeutics. In the present study, we explored the protective efficacy of vitamin D

Indexed as

Leishmaniasis, VisceralAdjuvants, ImmunologicAnimalsAntiprotozoal AgentsChenodeoxycholic AcidCholecalciferolCytokinesLeishmania donovaniMiceMice, Inbred BALB CTh1 CellsVitamin AAdjuvants, ImmunologicAntiprotozoal AgentsChenodeoxycholic AcidCholecalciferolCytokinesVitamin A

Identifiers

PMID31189939
PMCPMC6562038
OpenAlexW2951247428

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.